Is there evidence to support the use of direct Factor Xa inhibitors in coronary artery disease?
Doggrell, Sheila (2011) Is there evidence to support the use of direct Factor Xa inhibitors in coronary artery disease? Reviews on Recent Clinical Trials, 6(2), pp. 147-157.
Impact and interest:
Citation counts are sourced monthly from and citation databases.
These databases contain citations from different subsets of available publications and different time periods and thus the citation count from each is usually different. Some works are not in either database and no count is displayed. Scopus includes citations from articles published in 1996 onwards, and Web of Science® generally from 1980 onwards.
Citations counts from theindexing service can be viewed at the linked Google Scholar™ search.
|Item Type:||Journal Article|
|Keywords:||Apixaban, clinical pharmacology, clinical trials, coronary artery disease, DX-9065a, preclinical pharmacology, otamixaban, rivaroxaban, ZK-807834|
|Divisions:||Past > QUT Faculties & Divisions > Faculty of Science and Technology
Past > Schools > Pharmacy
|Deposited On:||19 Jul 2012 06:27|
|Last Modified:||03 Dec 2012 02:06|
Repository Staff Only: item control page